Phenytoin sodium

CAS No. 630-93-3

Phenytoin sodium( Phenytoin Sodium | Dilantin sodium | Diphenylhydantoin Sodium | 5,5-Diphenylhydantoin sodium salt | Diphantoine )

Catalog No. M15385 CAS No. 630-93-3

Phenytoin sodium is an inactive voltage-gated sodium channel stabilizer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G 48 In Stock

Biological Information

  • Product Name
    Phenytoin sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Phenytoin sodium is an inactive voltage-gated sodium channel stabilizer.
  • Description
    Phenytoin sodium is an inactive voltage-gated sodium channel stabilizer. (In Vitro):Phenytoin sodium is an antiepileptic drug. It is useful to treat partial seizures and generalized tonic-clonic seizures but not primary generalized seizures such as absence seizures or myoclonic seizures. Phenytoin is believed to protect against seizures by causing voltage-dependent block of voltage-gated sodium channels.Phenytoin has low affinity for resting sodium channels at hyperpolarized membrane potentials.When neurons are depolarized and the channels transition into the open and inactivated states, greater binding and block occur. The inhibitory potency is strongly use dependent, so that block accumulates with prolonged or repetitive activation, such as occurs during a seizure discharge. The blocking of sodium channels by phenytoin is of slow onset. The time course of fast sodium currents is therefore not altered in the presence of the drug and action potentials evoked by synaptic depolarizations of ordinary duration are not blocked. Thus phenytoin is able to selectively inhibit pathological hyperexcitability in epilepsy without unduly impairing ongoing activity. Phenytoin also blocks persistent sodium current and this may be of particular importance in seizure control. Phenytoin is a class 1b antiarrhythmic.
  • In Vitro
    Phenytoin sodium is an antiepileptic drug. It is useful to treat partial seizures and generalized tonic-clonic seizures but not primary generalized seizures such as absence seizures or myoclonic seizures. Phenytoin is believed to protect against seizures by causing voltage-dependent block of voltage-gated sodium channels. Phenytoin has low affinity for resting sodium channels at hyperpolarized membrane potentials. When neurons are depolarized and the channels transition into the open and inactivated states, greater binding and block occur. The inhibitory potency is strongly use dependent, so that block accumulates with prolonged or repetitive activation, such as occurs during a seizure discharge. The blocking of sodium channels by phenytoin is of slow onset. The time course of fast sodium currents is therefore not altered in the presence of the drug and action potentials evoked by synaptic depolarizations of ordinary duration are not blocked. Thus phenytoin is able to selectively inhibit pathological hyperexcitability in epilepsy without unduly impairing ongoing activity. Phenytoin also blocks persistent sodium current and this may be of particular importance in seizure control. Phenytoin is a class 1b antiarrhythmic.
  • In Vivo
    ——
  • Synonyms
    Phenytoin Sodium | Dilantin sodium | Diphenylhydantoin Sodium | 5,5-Diphenylhydantoin sodium salt | Diphantoine
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    630-93-3
  • Formula Weight
    274.25
  • Molecular Formula
    C15H11N2NaO2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 11 mg/mL (40.1 mM); Water: 3 mg/mL (10.93 mM); DMSO: 32 mg/mL (116.68 mM)
  • SMILES
    O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1
  • Chemical Name
    sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lenkowski PW, et al. Eur J Pharm Sci. 2004 Apr;21(5):635-44.
molnova catalog
related products
  • ABBV-318

    ABBV-318 can be used as small molecule Nav1.7/Nav1.8 blockers for the treatment of pain, with IC50 values of 2.8 μM for hNav1.7 and 3.8 μM for hNav1.8. ABBV-318 can be used to study pain-related disorders.

  • Pilsicainide HCl

    Pilsicainide HCl is a pure sodium channel blocker.

  • SM-6586

    SM-6586 is a potent calcium channel antagonist with inhibitory effects on Na+/H+ and Na+/Ca2+ exchange channels, and can be used in the study of cerebrovascular disease and hypertension, among other diseases.